Literature DB >> 861561

Recurrent laryngeal nerve paralysis in patients receiving vincristine and vinblastine.

J A Whittaker, I P Griffith.   

Abstract

Three patients receiving vincristine or binblastine developed recurrent laryngeal nerve paralysis, which resolved when the drug was withdrawn. The presence of mediastinal lymphadenopathy in patients with lymphoma may obscure the correct diagnosis, with the danger that the condition will produce respiratory distress if vinca alkaloid treatment is continued.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 861561      PMCID： PMC1607088          DOI： 10.1136/bmj.1.6071.1251

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  5 in total

Review 1.  THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.

Authors:  I S JOHNSON; J G ARMSTRONG; M GORMAN; J P BURNETT
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

2.  Vincristine in the treatment of lymphomas and leukemias.

Authors:  R A BOHANNON; D G MILLER; H D DIAMOND
Journal:  Cancer Res       Date:  1963-05       Impact factor: 12.701

3.  Vincristine treatment of advanced cancer: a cooperative study of 392 cases.

Authors:  J F Holland; C Scharlau; S Gailani; M J Krant; K B Olson; J Horton; B I Shnider; J J Lynch; A Owens; P P Carbone; J Colsky; D Grob; S P Miller; T C Hall
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

4.  Vincristine neuropathy. Clinical and electrophysiological observations.

Authors:  E B Casey; A M Jellife; P M Le Quesne; Y L Millett
Journal:  Brain       Date:  1973       Impact factor: 13.501

5.  Vocal cord paralysis: a toxic reaction to vinblastine (NSC-49842) therapy.

Authors:  J Brook; W Schreiber
Journal:  Cancer Chemother Rep       Date:  1971-12
  5 in total
  7 in total

Review 1.  Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects.

Authors:  P G Bain; P L Lantos; V Djurovic; I West
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 2.  Vincristine neurotoxicity. Pathophysiology and management.

Authors:  S S Legha
Journal:  Med Toxicol       Date:  1986 Nov-Dec

3.  Vincristine-induced recurrent laryngeal nerve paralysis in children.

Authors:  J D Tobias; P M Bozeman
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

4.  Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine.

Authors:  Serkan Feyyaz Yalin; Sinan Trabulus; Ayse Serap Yalin; Gulsah Yenidunya Yalin; Seniz Ongoren; Mehmet Riza Altiparmak
Journal:  Int J Clin Pharm       Date:  2013-01-22

5.  Unusual manifestations of vincristine neuropathy: report of two cases of hodgkin lymphoma.

Authors:  Sevgin Taner; Eren Gündüz; Ercan Kaya; Mahmut Kebapcı; Zafer Gülbaş
Journal:  Turk J Haematol       Date:  2014-09-05       Impact factor: 1.831

6.  Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review.

Authors:  Marie Lindhard Madsen; Hanne Due; Niels Ejskjær; Paw Jensen; Jakob Madsen; Karen Dybkær
Journal:  Cancer Chemother Pharmacol       Date:  2019-06-18       Impact factor: 3.333

7.  Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell lymphoma: a case report.

Authors:  Zarka Samoon; Munira Shabbir-Moosajee
Journal:  BMC Res Notes       Date:  2014-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.